Story perspectives

NHS Struggles with Flu Treatments Amid Cancer Care Crisis

12/21/2025

Center

Horby Expands Treatments

The NHS faces a shortage of effective treatments for severe influenza, especially H3N2 in the elderly.
Professor Sir Peter Horby, known for his Covid-19 work, expands the RECOVERY trial to test antivirals like Tamiflu and Xofluza for hospitalized flu patients.
Private chemotherapy appointments are soaring, highlighting pressures in cancer care and NHS targets being missed.
Patients turn to private options due to waiting times, raising concerns about NHS service adequacy.

Left

NHS Trials Dialive

The National Health Service will trial the Dialive device at thirteen hospitals to treat ACLF by cleansing the blood of toxins.
The National Institute for Health and Care Research (NIHR) funds the study, enrolling 72 patients to test whether Dialive resolves ACLF better than standard care.
If successful, it could reduce the need for liver transplants.
Experts say ACLF has a high mortality rate, underscoring the need for effective treatments.

1 of 2

Horby Expands Treatments

The NHS faces a shortage of effective treatments for severe influenza, especially H3N2 in the elderly.
Professor Sir Peter Horby, known for his Covid-19 work, expands the RECOVERY trial to test antivirals like Tamiflu and Xofluza for hospitalized flu patients.
Private chemotherapy appointments are soaring, highlighting pressures in cancer care and NHS targets being missed.
Patients turn to private options due to waiting times, raising concerns about NHS service adequacy.

1 / 2